(₹ crores) | Q1FY26 | Q4FY25 | Q1FY25 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 758.00 | 754.00 | 769.00 | 0.5% | -1.4% |
Total Expenses | 770.00 | 934.00 | 775.00 | -17.6% | -0.6% |
Profit Before Tax | -109.00 | -180.00 | -6.00 | -39.4% | 1716.7% |
Tax | -1.00 | -3.00 | 10.00 | -66.7% | -110.0% |
Profit After Tax | -108.00 | -177.00 | -16.00 | -39.0% | 575.0% |
Earnings Per Share | -5.30 | -11.60 | -0.90 | -54.3% | 488.9% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Wockhardt Ltd is a global pharmaceutical and biotechnology company, headquartered in India. The company is primarily engaged in the development and manufacturing of pharmaceutical and biotechnology products. It operates in various segments including formulations, active pharmaceutical ingredients (APIs), and biotechnology. Wockhardt has a significant presence in both domestic and international markets. The company is known for its focus on research and development, with several facilities dedicated to innovating new therapeutics. Recent developments or specific strategic shifts for Wockhardt Ltd are not detailed in the provided data.
For the quarter ending Q1FY26, Wockhardt Ltd reported a total income of ₹758.00 crores. This represents a slight increase of 0.5% compared to the previous quarter, Q4FY25, where the total income was ₹754.00 crores. However, when compared to the same quarter in the previous fiscal year, Q1FY25, there is a decrease of 1.4% from ₹769.00 crores. The revenue trends indicate a minor fluctuation in total income over the quarters and years, reflecting a consistent performance in revenue generation.
The company's profitability metrics indicate a narrowing of losses in Q1FY26. The Profit Before Tax (PBT) was recorded at -₹109.00 crores, which is an improvement from the previous quarter's PBT of -₹180.00 crores, marking a 39.4% reduction in losses. Compared to Q1FY25, where the PBT was -₹6.00 crores, there is a significant change of 1716.7%. The Profit After Tax (PAT) also shows a similar trend, reported at -₹108.00 crores in Q1FY26, compared to -₹177.00 crores in Q4FY25 (a 39.0% improvement) and -₹16.00 crores in Q1FY25 (a 575.0% change). The Earnings Per Share (EPS) follows this pattern, showing an EPS of -₹5.30 in Q1FY26, improved from -₹11.60 in Q4FY25, but a decrease from -₹0.90 in Q1FY25.
The total expenses for Wockhardt Ltd in Q1FY26 were ₹770.00 crores, which is a significant decrease of 17.6% from ₹934.00 crores in the previous quarter, Q4FY25. Compared to Q1FY25, the total expenses have marginally decreased by 0.6% from ₹775.00 crores. Tax expenses for Q1FY26 were reported at -₹1.00 crore, showing a decrease of 66.7% from the previous quarter and a notable change from ₹10.00 crores in Q1FY25. These metrics suggest a reduction in both total and tax expenses, contributing to the improved financial metrics despite persistent losses.
Wockhardt Ltd announced its Q1 FY 2025-26 results on 9 August, 2025.
Wockhardt Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
Key highlights of Wockhardt Ltd Q1 FY 2025-26 results include:
Wockhardt Ltd reported a net loss of ₹-108.00 crore in Q1 FY 2025-26, reflecting a 575.0% year-over-year growth.
Wockhardt Ltd posted a revenue of ₹758.00 crore in Q1 FY 2025-26.